Angiotensin II Type 1 Receptor–Associated Protein Is an Endogenous Inhibitor of Angiotensin II Type 1 Receptor Action in Cardiac Hypertrophy
Open Access
- 1 May 2010
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Hypertension
- Vol. 55 (5), 1086-1087
- https://doi.org/10.1161/HYPERTENSIONAHA.110.150458
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Cardiac-Specific Activation of Angiotensin II Type 1 Receptor–Associated Protein Completely Suppresses Cardiac Hypertrophy in Chronic Angiotensin II–Infused MiceHypertension, 2010
- Molecular determinants of angiotensin II type 1 receptor functional selectivityJournal of Molecular and Cellular Cardiology, 2009
- Angiotensin II: A hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talksPharmacology & Therapeutics, 2008
- Novel Regulatory Effect of Angiotensin II Type 1 Receptor-Interacting Molecule on Vascular Smooth Muscle CellsHypertension, 2007
- Attenuation of Inflammatory Vascular Remodeling by Angiotensin II Type 1 Receptor–Associated ProteinHypertension, 2006
- Pleiotropic AT1 Receptor Signaling Pathways Mediating Physiological and Pathogenic Actions of Angiotensin IIMolecular Endocrinology, 2006
- The novel angiotensin II type 1 receptor (AT1R)‐associated protein ATRAP downregulates AT1R and ameliorates cardiomyocyte hypertrophyFEBS Letters, 2005
- The Angiotensin II Type I Receptor-associated Protein, ATRAP, Is a Transmembrane Protein and a Modulator of Angiotensin II SignalingMolecular Biology of the Cell, 2003
- ATRAP, Novel AT1 Receptor Associated Protein, Enhances Internalization of AT1 Receptor and Inhibits Vascular Smooth Muscle Cell GrowthBiochemical and Biophysical Research Communications, 2000
- Cloning and Characterization of ATRAP, a Novel Protein That Interacts with the Angiotensin II Type 1 ReceptorOnline Journal of Public Health Informatics, 1999